Patients with blood cancers often face major insurance hurdles and significant out-of-pocket costs when trying to access specialty oral anticancer medications, according to a new nationwide study led by researchers at the Perelman School of Medicine at the University of Pennsylvania.
❓ Unknown
Insurance Barriers Hinder Access to Blood Cancer Treatments
Just now
September 30, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
A nationwide study reveals that patients with blood cancers in the U.S. face significant insurance barriers and high out-of-pocket costs for accessing specialty oral anticancer medications. This issue highlights the broader challenges of healthcare access that could resonate with similar problems in Iran's healthcare system. Understanding these barriers is crucial as Iran navigates its own healthcare challenges amidst economic sanctions.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
8 min ago •
Study Reveals Learned Social Behavior in Genetically Identical Fish
10 min ago •
Human Rights Council Meeting on Palestine Held in Absence of Human Rights Claimants
18 min ago •
Florida State University Researchers Enhance Durability of Radiation-Detecting Materials
18 min ago •
Atlas of Immune Cells Reveals Genetic Variants Linked to Disease Risk
18 min ago •